E-drug: Registration Requirement for Combination Products (cont)
----------------------------------------------------------------
Dear Chris,
WHO GTB program have done a lot of work on this problem. The person who did
most of the work is Marius Fourie from South Africa and he has done truly
excellent work. He has done detailed bio availability studies on 2, 3 and 4
drug combinations showing that with good formulation these multiple
combinations were effective and bio available. There will be a publication
very soon documenting these studies, I have copies of the papers and the
charts if you want me to send these to you.
Best wishes,
Richard
Richard Laing
Associate Professor
Department of International Health
Boston University School of Public Health
715 Albany St
Boston MA 02118-2526
E-mail richardl@bu.edu
Tel 617 414-1444
Fax 617 638-4476
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.